Skip to content

The prevention effect of electrical impedance tomography(EIT)-guided protective ventilation against postoperative pulmonary complications in high-risk patients undergoing laparoscopic radical rectectomy

The prophylactic effect of driving pressure-guided protective ventilation combined with deep neuromuscular block against postoperative pulmonary complications of high-risk patients after laparoscopic colorectal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076677
Enrollment
Unknown
Registered
2023-10-16
Start date
2023-10-16
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative Pulmonary Complications

Interventions

Intervention group:EIT-guided pulmonary protected ventilation
Control group:Conventional pulmonary protective ventilation

Sponsors

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 90; 2. Elective laparoscopic radical rectectomy under general anesthesia; 3.ASA grade 2 to 3; 4. Operation time >=2h; 5. Patients athigh risk of postoperative pulmonary complications (ARISCAT score > 44).

Exclusion criteria

Exclusion criteria: 1. Unable to obtain informed consent to participate in the study; 2. Turn to open, emergency operation; 3. Comply with any of the following: (1) History of any lung and / or abdominal surgery, history of asthma or chronic obstructive pulmonary disease, acute lung injury or acute respiratory distress syndrome, which is expected to require long mechanical ventilation after surgery; (2) Persistent hemodynamic instability, intractable shock, and severe heart disease (defined as conforming to the New York Heart Association III or IV cardiac function, or acute coronary syndrome, or persistent ventricular tachycardia); (3) Patients with cerebral stroke within three months before surgery; (4) Renal insufficiency (SCr is more than 2 times the normal reference range of our hospital, and the urine volume is less than 0.5ml/(kg·h), and the glomerular filtration rate is less than 60ml/h or proteinuria); (5) Cirrhosis (Child B or C); (6) Recent immunosuppressive therapy (defined as the need for chemotherapy or radiotherapy) is less than two months from the last chemotherapy or radiotherapy; (7) Allergy to narcotic drugs, suspected or suspected malignant hyperthermia (family) history; (8) Pregnancy (excluded by laboratory examination); (9) Any or suspected neuromuscular disease; (10) The physician in charge thinks it is not suitable for this study.

Design outcomes

Primary

MeasureTime frame
Postoperative pulmonary complications;

Secondary

MeasureTime frame
Intraoperative ventilation index;Surgical Rating Scale, SRS;Plasma lung injury markers;Inflammatory factor;Duration of hospital stay;Postoperative pain;Postoperative nausea and vomiting;Pulmonary ventilation changes;

Countries

China

Contacts

Public ContactYan Tao

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

blizzardyt@163.com+86 135 2255 3375

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026